Cover Image

What is Currently Known About the SARS-CoV2 Variants of Concern

Saved in:

Bibliographic Details
Main Authors:	Tarek Souaid (Author), Joya-Rita Hindy (Author), Souha S. Kanj (Author)
Format:	Book
Published:	Springer, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cervical osteomyelitis potentially caused by Campylobacter fetus
by: Bassem Awada, et al.
Published: (2021)

Immune Profile of SARS-CoV-2 Variants of Concern
by: Caterina A. M. La Porta, et al.
Published: (2021)

Human immune response to SARS-CoV-2: What is known? A scoping review
by: Ivon Johanna Rodriguez
Published: (2020)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
by: Lixin Lin, et al.
Published: (2021)

Dynamics of SARS-CoV-2 Variants of Concern in Brazil, Early 2021
by: José Eduardo Levi, et al.
Published: (2021)

Omicron variant in the current SARS-CoV-2 pandemic
by: Kaveh Nasiri, et al.
Published: (2022)

Challenges to Antimicrobial Stewardship in the Countries of the Arab League: Concerns of Worsening Resistance during the COVID-19 Pandemic and Proposed Solutions
by: Nesrine A. Rizk, et al.
Published: (2021)

Antimicrobial Treatment of <i>Pseudomonas aeruginosa</i> Severe Sepsis
by: Johnny Zakhour, et al.
Published: (2022)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022)

SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population
by: Anahí Maldonado-Cabrera, et al.
Published: (2023)

Emergence of SARS‐CoV‐2 variants KP.2 and KP.3 sparks concerns: What should we do?
by: Balamurugan Shanmugaraj
Published: (2024)

Saliva as a Potential SARS-CoV-2 Reservoir: What is Already Known? A Systematic Review
by: Luciana Munhoz, et al.
Published: (2021)

Health system impacts of SARS-CoV − 2 variants of concern: a rapid review
by: Justine Dol, et al.
Published: (2022)

Observations on the current outbreak of the SARS-CoV-2 Delta Variant in Sydney
by: Rick Nunes-Vaz, et al.
Published: (2021)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

What is currently known about endometrial cancer in Lynch syndrome? - review
by: Agnieszka Kwiatkowska, et al.
Published: (2019)

What is currently known about endometrial cancer in Lynch syndrome? - review
by: Agnieszka Kwiatkowska, et al.
Published: (2019)

What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?
by: Roberto Scendoni, et al.
Published: (2023)

Decoding the next SARS-CoV-2 variant
by: Jeremy Nel, et al.
Published: (2022)

Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study
by: Li Li, et al.
Published: (2022)

Outbreak of P.3 (Theta) SARS-CoV-2 emerging variant of concern among service workers in Louisiana
by: Rebecca Rose, et al.
Published: (2022)

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
by: Bo-Seong Jeong, et al.
Published: (2022)

Transmission and containment of the SARS-CoV-2 Delta variant of concern in Guangzhou, China: A population-based study.
by: Li Li, et al.
Published: (2022)

A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
by: Michela Murdocca, et al.
Published: (2024)

The Emergence and Spread of Novel SARS-CoV-2 Variants
by: Huaimin Yi, et al.
Published: (2021)

Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants
by: Zhe Ding, et al.
Published: (2022)

Travel history among persons infected with SARS-CoV-2 variants of concern in the United States, December 2020-February 2021
by: Alicia Dunajcik, et al.
Published: (2023)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
by: Peter J. Halfmann, et al.
Published: (2021)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report
by: Karim Souaid, et al.
Published: (2021)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022)

Systems Thinking About SARS-CoV-2
by: Rainer Johannes Klement
Published: (2020)

Different SARS-CoV-2 variants, same prevention strategies
by: Tafadzwa Dzinamarira, et al.
Published: (2022)

Screening for inhibitors against SARS-CoV-2 and its variants
by: Weijing Yuan, et al.
Published: (2022)

Importation of SARS-CoV-2 Omicron variant in Beijing, China
by: Fu Li, et al.
Published: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021)

Genetic variants of SARS-CoV-2 and its clinical implications
by: Alexander Expósito Lara, et al.
Published: (2021)

Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022)

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant
by: Nirmitee Mulgaonkar, et al.
Published: (2023)

SARS-CoV-2 anti-N antibodies among healthcare personnel without previous known COVID-19
by: Sajal Tiwary, et al.
Published: (2024)